Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Juvent is a medical technology company specializing in non-invasive regenerative therapies through its proprietary Micro-Impact Platform. The company's flagship product uses low-magnitude mechanical stimulation (LMMS) to deliver precise, high-frequency vibrations that stimulate bone growth and improve musculoskeletal health. Clinically validated for treating osteoporosis and osteopenia, Juvent's technology is also utilized for athletic recovery and joint pain management. The device is FDA-registered as a Class I exercise device and has been the subject of numerous NIH-funded studies. Juvent aims to provide a drug-free alternative for maintaining bone density and enhancing physical performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Juvent.